title: Pulmonary toxicities from targeted therapies: a review.
abstract: Pulmonary toxicity is rarely seen with most commonly used targeted therapies. The endothelial growth factor receptor (EGFR) small-molecule tyrosine kinase inhibitors (TKIs) gefitinib and erlotinib can cause interstitial lung disease (ILD). BCR-ABL tyrosine kinase inhibitors imatinib and dasatinib can cause pleural effusions. Infusion-related bronchospasm is common with the monoclonal antibodies to EGFR cetuximab and panitumumab, and case reports of bronchiolitis and pulmonary fibrosis have been described. Up to one-sixth of patients taking mammalian target of rapamycin (mTOR) inhibitors get a reversible interstitial pneumonitis. Bevacizumab, the monoclonal antibody to vascular endothelial growth factor (VEGF), has been associated with hemoptysis and pulmonary embolism particularly in patients with squamous cell lung cancer. Infusion-related bronchospasms, acute respiratory distress syndrome (ARDS), and interstitial pneumonitis can be seen with the anti-lymphocyte monoclonal antibodies rituximab, ofatumumab, and alemtuzumab. While most pulmonary toxicities from these therapies are mild and resolve promptly with dose reduction or discontinuation, it is important for the clinician to recognize these potential toxicities when faced with treatment-related complications. Discerning these pulmonary adverse effects may help in making decisions on diagnostic testing and therapy, particularly for those with pulmonary and cardiovascular co-morbidities.
authors.affiliation: Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, USA.
authors.forename: Nicholas A
authors.initials: NA
authors.lastname: Barber
authors.forename: Apar Kishor
authors.initials: AK
authors.lastname: Ganti
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000494:pharmacology; D006801:Humans; D008171:Lung Diseases / Q000139:chemically induced* / Q000378:metabolism; D058990:Molecular Targeted Therapy / Q000009:adverse effects* / Q000379:methods
chemical_list: D000970:Antineoplastic Agents
references.citation: N Engl J Med. 2009 Sep 3;361(10):947-57
references.pmid: 19692680
references.citation: J Clin Oncol. 2003 Jun 15;21(12):2237-46
references.pmid: 12748244
references.citation: Am J Respir Crit Care Med. 2007 Oct 15;176(8):814-8
references.pmid: 17600277
references.citation: Blood. 2004 May 1;103(9):3278-81
references.pmid: 14726385
references.citation: Chest. 2007 Sep;132(3):1042-4
references.pmid: 17873198
references.citation: Oncologist. 2005 Aug;10(7):461-6
references.pmid: 16079312
references.citation: J Clin Oncol. 2007 Sep 1;25(25):3908-14
references.pmid: 17761974
references.citation: Transplantation. 2004 Apr 27;77(8):1215-20
references.pmid: 15114088
references.citation: Chest. 2010 Feb;137(2):456-9
references.pmid: 20133293
references.citation: JAMA. 2006 Dec 6;296(21):2558-60
references.pmid: 17148721
references.citation: Eur J Haematol. 2009 Jan;82(1):73-4
references.pmid: 18754854
references.citation: N Engl J Med. 2003 Jun 26;348(26):2690-1; discussion 2690-1
references.pmid: 12826649
references.citation: N Engl J Med. 2006 Dec 7;355(23):2408-17
references.pmid: 17151364
references.citation: JAMA. 2003 Oct 22;290(16):2149-58
references.pmid: 14570950
references.citation: N Engl J Med. 2006 Dec 14;355(24):2542-50
references.pmid: 17167137
references.citation: N Engl J Med. 2004 Jun 3;350(23):2335-42
references.pmid: 15175435
references.citation: Blood. 2006 May 1;107(9):3492-4
references.pmid: 16410442
references.citation: N Engl J Med. 2008 Aug 28;359(9):906-17
references.pmid: 18753647
references.citation: Intern Med. 2008;47(6):533-6
references.pmid: 18344641
references.citation: Br J Haematol. 2004 May;125(4):420
references.pmid: 15142112
references.citation: J Clin Oncol. 2011 May 1;29(13):1750-6
references.pmid: 21444868
references.citation: Br J Haematol. 2009 Jul;146(2):164-70
references.pmid: 19545290
references.citation: J Clin Oncol. 2007 May 20;25(15):1960-6
references.pmid: 17452677
references.citation: J Clin Oncol. 2007 Apr 20;25(12):1545-52
references.pmid: 17442998
references.citation: Yonsei Med J. 2008 Feb 29;49(1):155-8
references.pmid: 18306483
references.citation: N Engl J Med. 2010 Jun 24;362(25):2380-8
references.pmid: 20573926
references.citation: Mod Rheumatol. 2008;18(2):208-11
references.pmid: 18306979
references.citation: J Clin Oncol. 2004 Jun 1;22(11):2184-91
references.pmid: 15169807
references.citation: Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6290S-5S
references.pmid: 15448019
references.citation: Blood. 2002 May 15;99(10):3554-61
references.pmid: 11986207
references.citation: N Engl J Med. 2008 Sep 11;359(11):1116-27
references.pmid: 18784101
references.citation: BMC Cancer. 2007 Aug 05;7:150
references.pmid: 17683587
references.citation: Blood. 2005 Dec 15;106(13):4050-3
references.pmid: 16118317
references.citation: Lancet. 2003 Jan 11;361(9352):137-9
references.pmid: 12531582
references.citation: Am J Hematol. 2004 Sep;77(1):103-4
references.pmid: 15307117
references.citation: Am J Respir Crit Care Med. 2010 Aug 1;182(3):396-403
references.pmid: 20194812
references.citation: Cancer. 2010 Sep 15;116(18):4256-65
references.pmid: 20549832
references.citation: J Clin Oncol. 2005 Sep 1;23(25):5892-9
references.pmid: 16043829
references.citation: J Clin Oncol. 2007 May 1;25(13):1658-64
references.pmid: 17470858
references.citation: J Clin Oncol. 2007 Aug 1;25(22):3380-1
references.pmid: 17664489
references.citation: Korean J Intern Med. 2010 Mar;25(1):86-92
references.pmid: 20195409
references.citation: Blood. 2007 Jun 15;109(12):5143-50
references.pmid: 17317857
references.citation: Ann Oncol. 2008 Aug;19(8):1387-1392
references.pmid: 18385198
references.citation: Mayo Clin Proc. 2004 Jul;79(7):949, 953
references.pmid: 15244399
references.citation: J Clin Oncol. 2006 Jan 20;24(3):431-6
references.pmid: 16365178
references.citation: Eur Respir J. 2010 Mar;35(3):681-7
references.pmid: 19608586
references.citation: Am J Hematol. 2005 May;79(1):80-1
references.pmid: 15849772
references.citation: N Engl J Med. 2006 Oct 5;355(14):1456-65
references.pmid: 17021321
references.citation: J Clin Oncol. 2006 Jun 1;24(16):2549-56
references.pmid: 16735708
references.citation: Science. 2004 Jun 4;304(5676):1497-500
references.pmid: 15118125
references.citation: N Engl J Med. 2009 Apr 2;360(14):1408-17
references.pmid: 19339720
references.citation: J Clin Oncol. 2005 Apr 1;23(10):2425-6
references.pmid: 15800335
references.citation: Int J Gen Med. 2010 Apr 08;3:31-6
references.pmid: 20463821
references.citation: N Engl J Med. 2003 Mar 13;348(11):994-1004
references.pmid: 12637609
references.citation: N Engl J Med. 2006 Dec 28;355(26):2733-43
references.pmid: 17192538
references.citation: Lancet. 2009 Mar 28;373(9669):1097-104
references.pmid: 19303137
references.citation: J Clin Oncol. 2008 Nov 20;26(33):5422-8
references.pmid: 18936475
references.citation: Ann Oncol. 2010 Oct;21(10):2119-2120
references.pmid: 20720089
references.citation: Eur J Cancer. 2006 Aug;42(12):1875-80
references.pmid: 16806903
references.citation: Drug Saf. 2005;28(2):103-13
references.pmid: 15691221
references.citation: N Engl J Med. 2010 Jun 17;362(24):2251-9
references.pmid: 20525993
references.citation: Lancet. 2008 Aug 9;372(9637):449-56
references.pmid: 18653228
references.citation: Gut Liver. 2010 Dec;4(4):543-6
references.pmid: 21253306
references.citation: N Engl J Med. 2007 May 31;356(22):2271-81
references.pmid: 17538086
references.citation: Clin Cancer Res. 2008 Mar 1;14(5):1296-302
references.pmid: 18316547
references.citation: N Engl J Med. 2010 Jun 17;362(24):2260-70
references.pmid: 20525995
references.citation: Rheumatology (Oxford). 2009 Apr;48(4):447-8
references.pmid: 19202159
references.citation: N Engl J Med. 2001 Mar 15;344(11):783-92
references.pmid: 11248153
references.citation: Clin Colorectal Cancer. 2009 Apr;8(2):118-20
references.pmid: 19739274
references.citation: Cases J. 2008 Sep 08;1(1):143
references.pmid: 18778468
references.citation: Ann Oncol. 2006 Mar;17(3):372-9
references.pmid: 16291774
references.citation: Clin Lymphoma Myeloma. 2006 Mar;6(5):407-9
references.pmid: 16640819
references.citation: J Clin Oncol. 2009 Feb 10;27(5):663-71
references.pmid: 19114683
references.citation: Oncologist. 2003;8(4):303-6
references.pmid: 12897327
references.citation: Blood. 2008 Feb 1;111(3):1094-100
references.pmid: 18003886
references.citation: N Engl J Med. 2002 Aug 15;347(7):472-80
references.pmid: 12181401
references.citation: N Engl J Med. 2005 Oct 20;353(16):1673-84
references.pmid: 16236738
references.citation: South Med J. 2006 Nov;99(11):1292-4
references.pmid: 17195429
references.citation: Oncologist. 2007 May;12(5):601-9
references.pmid: 17522249
references.citation: Chest. 2008 Jun;133(6):1476-1478
references.pmid: 18574290
references.citation: Respiration. 2008;75(3):350-4
references.pmid: 16449804